查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2056650

全球貓疫苗市場：市場規模、佔有率、趨勢和成長分析（2026-2034）

Global Cat Vaccine Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球貓疫苗市場預計將從2025年的22.1億美元成長至2034年的50.1億美元，2026年至2034年的複合年成長率（CAGR）為9.53%。該市場正經歷顯著成長，主要得益於人們對寵物健康保健意識的提高以及全球伴侶動物數量的不斷成長。貓疫苗在預防感染疾病、促進動物健康和延長壽命方面發揮著至關重要的作用。獸醫支出增加、寵物飼養量上升以及人們對動物福利日益成長的關注是推動市場擴張的主要因素。獸醫院和寵物飼主對預防性護理的日益重視也促進了全球對疫苗產品需求的成長。

貓科傳染病日益普遍以及獸醫學的進步是推動市場成長的關鍵因素。製藥公司正投資研發療效更廣、安全性更高的先進疫苗。政府推出的促進動物健康管理和疫苗接種計劃的法規也促進了疫苗的推廣。此外，人們對通用感染疾病和寵物預防保健意識的提高，也為已開發國家和發展中國家的獸藥生產商創造了巨大的商機。

動物生物技術的持續進步以及寵物「人性化」趨勢的日益成長，為貓科疫苗市場帶來了極其樂觀的未來前景。預計各公司將專注於創新疫苗配方、聯合疫苗以及改進的給藥系統，以提高治療效果和便利性。寵物保險覆蓋範圍的擴大和數位化獸醫平台的普及也將進一步推動市場成長。在新興市場，隨著寵物擁有率和獸醫基礎設施的不斷完善，預計市場需求將持續成長。

我們的報告經過精心撰寫，旨在為客戶提供有關各個行業和市場的全面且切實可行的見解。每份報告都包含幾個關鍵要素，以便全面了解市場狀況：

市場概覽：有關市場的詳細資訊，包括定義、分類和行業現狀。

市場動態：本節詳細分析影響市場成長的主要促進因素、限制因素、機會和挑戰。本節將檢驗技術進步、監管變化和新興趨勢等因素。

細分市場分析：市場根據產品類型、應用、最終用戶和地區等標準分類為若干清晰的細分市場。此分析揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要參與者進行全面評估，包括市場佔有率、產品系列、策略舉措和財務表現。我們深入分析這些主要參與者的競爭動態和關鍵策略。

市場預測：基於歷史數據和當前市場狀況，我們對特定時期內的市場規模和成長趨勢進行預測。這包括定量分析和圖表展示，以展現未來的市場軌跡。

區域分析：這包括評估每個區域的市場表現，並識別關鍵市場和區域趨勢。它有助於了解區域市場動態和商業機會。

新趨勢與機會：識別當前及未來市場趨勢、技術創新和潛在投資領域。深入分析未來市場發展和成長前景。

客製化選項：我們提供靈活的客製化服務，可根據您的特定需求量身訂做報告。這包括額外的市場細分、國家/地區特定分析、競爭對手概況、自訂資料點以及針對特定細分市場的重點分析，從而更好地支援策略決策。

目錄

第1章：引言

第2章執行摘要

第3章：市場波動因素、趨勢與框架

  • 市場歷史及展望
  • 滲透率和成長率預測：繪製圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 分析法規的影響
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球貓疫苗市場：依疫苗類型分類

  • 市場分析、考量與預測
  • 改良活病毒疫苗/減毒活病毒疫苗
  • 失活
  • 其他

第5章：全球貓疫苗市場：依疾病類型分類

  • 市場分析、考量與預測
  • 貓白血病
  • 貓泛白血球減少症（貓瘟）
  • 貓呼吸道疾病
  • 貓咪狂犬病
  • 其他疾病

第6章：全球貓疫苗市場：依給藥途徑分類

  • 市場分析、考量與預測
  • 注射藥物
  • 鼻內
  • 口服

第7章：全球貓疫苗市場：依免疫持續時間分類

  • 市場分析、考量與預測
  • 1年
  • 3年
  • 其他

第8章：全球貓疫苗市場：依成分分類

  • 市場分析、考量與預測
  • 聯合疫苗
  • 疫苗單價

第9章：全球貓疫苗市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測。
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測。
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 對拉丁美洲市場的分析、洞察與預測。
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 對中東和非洲市場的分析、洞察和預測。
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Virbac
    • CH Boehringer Sohn AG & Co. KG
    • Elanco
    • Zoetis
    • Merck & Co
    • Bioveta As
    • Indian Immunologicals Ltd
簡介目錄
Product Code: VMR112118339

The global cat vaccine market size is expected to reach USD 5.01 Billion in 2034 from USD 2.21 Billion in 2025, growing at a CAGR of 9.53 during 2026-2034.This market is experiencing significant growth due to increasing awareness regarding pet healthcare and the rising adoption of companion animals worldwide. Cat vaccines play a critical role in preventing infectious diseases and improving animal health and longevity. Growing expenditure on veterinary care, increasing pet ownership, and rising concern for animal welfare are significantly driving market expansion. Veterinary clinics, animal hospitals, and pet owners are increasingly prioritizing preventive healthcare measures, contributing to higher demand for vaccination products globally.

The increasing prevalence of infectious feline diseases and advancements in veterinary medicine are major factors supporting market growth. Pharmaceutical companies are investing in the development of advanced vaccines that provide broader protection and improved safety profiles. Government regulations promoting animal health management and vaccination programs are also encouraging wider vaccine adoption. In addition, rising awareness regarding zoonotic diseases and preventive pet healthcare is creating substantial opportunities for veterinary pharmaceutical manufacturers across developed and developing regions.

Future prospects for the cat vaccine market remain highly favorable due to continuous advancements in veterinary biotechnology and growing pet humanization trends. Companies are expected to focus on innovative vaccine formulations, combination vaccines, and improved delivery systems to enhance treatment effectiveness and convenience. The expansion of pet insurance coverage and digital veterinary healthcare platforms is likely to further support market growth. Emerging economies are also anticipated to witness increased demand as pet ownership rates and veterinary healthcare infrastructure continue to expand.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Vaccine Type

  • Modified/Attenuated Live
  • Inactivated (Killed)
  • Others

By Disease Type

  • Feline Leukemia
  • Feline Panleukopenia (Feline Distemper)
  • Feline Respiratory Diseases
  • Feline Rabies
  • Other Diseases

By Route of Administration

  • Injectables
  • Intranasal
  • Oral

By Duration of Immunity

  • 1 Year
  • 3 Year
  • Others

By Component

  • Combined Vaccines
  • Mono Vaccines

COMPANIES PROFILED

  • Virbac, C.H. Boehringer Sohn AG & Co. KG., Elanco, Zoetis, Merck & Co., Bioveta a.s., Indian Immunologicals Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CAT VACCINE MARKET: BY VACCINE TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Vaccine Type
  • 4.2. Modified/Attenuated Live Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Inactivated (Killed) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CAT VACCINE MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Disease Type
  • 5.2. Feline Leukemia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Feline Panleukopenia (Feline Distemper) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Feline Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Feline Rabies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Other Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CAT VACCINE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Route Of Administration
  • 6.2. Injectables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Intranasal Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CAT VACCINE MARKET: BY DURATION OF IMMUNITY 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Duration Of Immunity
  • 7.2. 1 Year Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. 3 Year Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CAT VACCINE MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Component
  • 8.2. Combined Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Mono Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL CAT VACCINE MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Vaccine Type
    • 9.2.2 By Disease Type
    • 9.2.3 By Route Of Administration
    • 9.2.4 By Duration Of Immunity
    • 9.2.5 By Component
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Vaccine Type
    • 9.3.2 By Disease Type
    • 9.3.3 By Route Of Administration
    • 9.3.4 By Duration Of Immunity
    • 9.3.5 By Component
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Vaccine Type
    • 9.4.2 By Disease Type
    • 9.4.3 By Route Of Administration
    • 9.4.4 By Duration Of Immunity
    • 9.4.5 By Component
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Vaccine Type
    • 9.5.2 By Disease Type
    • 9.5.3 By Route Of Administration
    • 9.5.4 By Duration Of Immunity
    • 9.5.5 By Component
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Vaccine Type
    • 9.6.2 By Disease Type
    • 9.6.3 By Route Of Administration
    • 9.6.4 By Duration Of Immunity
    • 9.6.5 By Component
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL CAT VACCINE INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Virbac
    • 11.2.2 C.H. Boehringer Sohn AG & Co. KG
    • 11.2.3 Elanco
    • 11.2.4 Zoetis
    • 11.2.5 Merck & Co
    • 11.2.6 Bioveta A.s
    • 11.2.7 Indian Immunologicals Ltd